191 related articles for article (PubMed ID: 29242151)
21. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity.
Kundu JK; Shin YK; Kim SH; Surh YJ
Carcinogenesis; 2006 Jul; 27(7):1465-74. PubMed ID: 16474181
[TBL] [Abstract][Full Text] [Related]
22. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
[TBL] [Abstract][Full Text] [Related]
23. [Involvement of p38-p53 signal pathway in resveratrol-induced apoptosis in MCF-7 cells].
Zhang YH; Guo JG; Guo ZH; Xie SQ
Yao Xue Xue Bao; 2011 Nov; 46(11):1332-7. PubMed ID: 22260024
[TBL] [Abstract][Full Text] [Related]
24. Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro.
Hsieh TC; Huang YC; Wu JM
Carcinogenesis; 2011 Jan; 32(1):93-101. PubMed ID: 21045015
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
Gill C; Walsh SE; Morrissey C; Fitzpatrick JM; Watson RW
Prostate; 2007 Nov; 67(15):1641-53. PubMed ID: 17823925
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
[TBL] [Abstract][Full Text] [Related]
27. Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells.
Zhang S; Cao HJ; Davis FB; Tang HY; Davis PJ; Lin HY
Br J Cancer; 2004 Jul; 91(1):178-85. PubMed ID: 15188005
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways.
Kim AL; Zhu Y; Zhu H; Han L; Kopelovich L; Bickers DR; Athar M
Exp Dermatol; 2006 Jul; 15(7):538-46. PubMed ID: 16761963
[TBL] [Abstract][Full Text] [Related]
29. Gambogic Acid Induces Cell Apoptosis and Inhibits MAPK Pathway in PTEN
Pan H; Lu LY; Wang XQ; Li BX; Kelly K; Lin HS
Chin J Integr Med; 2018 Feb; 24(2):109-116. PubMed ID: 28578487
[TBL] [Abstract][Full Text] [Related]
30. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
Hsieh TC
Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yu K; Yao S; Levine AC
J Biol Chem; 2005 Feb; 280(5):3817-23. PubMed ID: 15550400
[TBL] [Abstract][Full Text] [Related]
33. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.
She QB; Bode AM; Ma WY; Chen NY; Dong Z
Cancer Res; 2001 Feb; 61(4):1604-10. PubMed ID: 11245472
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism.
Shih A; Davis FB; Lin HY; Davis PJ
J Clin Endocrinol Metab; 2002 Mar; 87(3):1223-32. PubMed ID: 11889192
[TBL] [Abstract][Full Text] [Related]
37. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
[TBL] [Abstract][Full Text] [Related]
38. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.
Narayanan BA; Narayanan NK; Re GG; Nixon DW
Int J Cancer; 2003 Mar; 104(2):204-12. PubMed ID: 12569576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
